{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:50:23Z","timestamp":1790113823321,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["207569\/Z\/17\/Z"],"award-info":[{"award-number":["207569\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110330\/Z\/15\/Z"],"award-info":[{"award-number":["110330\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2017\/694169-1"],"award-info":[{"award-number":["2017\/694169-1"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.vaccine.2019.05.035","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T17:32:25Z","timestamp":1563384745000},"page":"A28-A34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S1","title":["Rabies vaccine and immunoglobulin supply and logistics: Challenges and opportunities for rabies elimination in Kenya"],"prefix":"10.1016","volume":"37","author":[{"given":"Gati","family":"Wambura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athman","family":"Mwatondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Muturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyne","family":"Nasimiyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diorbhail","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-6884","authenticated-orcid":false,"given":"Katie","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philet","family":"Bichanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collins","family":"Tabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Juma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Ngere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SM","family":"Thumbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.05.035_b0005","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1016\/S2214-109X(16)30245-5","article-title":"2016: the beginning of the end of rabies?","volume":"4","author":"Abela-Ridder","year":"2016","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.vaccine.2019.05.035_b0010","first-page":"4","article-title":"The feasibility of canine rabies elimination in Africa: Dispelling doubts with data","author":"Lembo","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.035_b0015","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.05.035_b0020","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1126\/science.1256306","article-title":"Infectious disease. Implementing Pasteur\u2019s vision for rabies elimination","volume":"345","author":"Lankester","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.05.035_b0025","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.035_b0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2015.10.002","article-title":"The Pan-African Rabies Control Network (PARACON): A unified approach to eliminating canine rabies in Africa","volume":"124","author":"Scott","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2019.05.035_b0035","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1016\/j.vaccine.2012.03.069","article-title":"Canine rabies vaccination and domestic dog population characteristics in the developing world: A systematic review","volume":"30","author":"Davlin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.035_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003447","article-title":"Review on dog rabies vaccination coverage in Africa: A question of dog accessibility or cost recovery?","volume":"9","author":"Jibat","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.035_b0045","doi-asserted-by":"crossref","unstructured":"Cleaveland S, Thumbi SM. Proof of concept of mass dog vaccination for the control and elimination of canine rabies 2018;37.","DOI":"10.20506\/rst.37.2.2824"},{"key":"10.1016\/j.vaccine.2019.05.035_b0050","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.vaccine.2013.12.031","article-title":"Rabies: underused vaccines, unnecessary deaths","volume":"32","author":"Dodet","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.035_b0055","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.vaccine.2018.06.061","article-title":"Rabies vaccines: WHO position paper, April 2018 - Recommendations","volume":"36","author":"World Health Organization","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.035_b0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coviro.2012.03.007","article-title":"The role of vaccination in rabies prevention","volume":"2","author":"Briggs","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2019.05.035_b0065","first-page":"2","article-title":"Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies","author":"Hampson","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.035_b0070","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/j.ijid.2011.03.023","article-title":"Clinical and epidemiological features of human rabies cases in the Philippines: A review from 1987 to 2006","volume":"15","author":"Dimaano","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.035_b0075","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2013.06.083","article-title":"Trend of human rabies prophylaxis in developing countries: Toward optimal rabies immunization","volume":"31","author":"Permpalung","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.035_b0080","unstructured":"Bitek A, Eric O, Nanyingi M, Muthiani Y, Mathew M, Muriithi R, et al. A hundred years of rabies in Kenya and the strategy for its elimination by 2030. (In-Submission) n.d."},{"key":"10.1016\/j.vaccine.2019.05.035_b0085","unstructured":"ZDU. Strategic plan for the elimination of human rabies in Kenya. NAIROBI; 2014."},{"key":"10.1016\/j.vaccine.2019.05.035_b0090","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.vaccine.2017.03.001","article-title":"Rabies: Still a silent killer targeting the poor","volume":"35","author":"Wilde","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.035_b0095","doi-asserted-by":"crossref","unstructured":"WHO Rabies Modelling Consortium. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries\u202f: a modelling study 2019;19. doi:10.1016\/S1473-3099(18)30512-7.","DOI":"10.1016\/S1473-3099(18)30606-6"},{"key":"10.1016\/j.vaccine.2019.05.035_b0100","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1016\/j.vaccine.2012.04.041","article-title":"How influenza vaccination policy may affect vaccine logistics","volume":"30","author":"Assi","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.035_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101114","article-title":"Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries","volume":"9","author":"Levin","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.035_b0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fvets.2017.00018","article-title":"Addressing the disconnect between the estimated, reported, and true rabies data: the development of a regional African rabies bulletin","volume":"4","author":"Scott","year":"2017","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2019.05.035_b0115","doi-asserted-by":"crossref","unstructured":"Bharti OK, Madhusudana SN, Kale A, Gaunta PL, Chaudhry LS, Kumar J, et al. Success story of a low cost intra-dermal rabies vaccination (IDRV) clinic-lessons learnt over five years of 12,000 patient vaccinations \u201cwithout failure\u201d at DDU Hospital Shimla, Himachal Pradesh, India; 2015:129\u201339.","DOI":"10.4236\/wjv.2015.53014"},{"key":"10.1016\/j.vaccine.2019.05.035_b0120","first-page":"1","article-title":"Barriers to innovation in human rabies prophylaxis and treatment: A causal analysis of insights from key opinion leaders and literature","author":"van de Burgwal","year":"2017","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.vaccine.2019.05.035_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004245","article-title":"Establishment of a canine rabies burden in haiti through the implementation of a novel surveillance program","volume":"9","author":"Wallace","year":"2015","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:34:28Z","timestamp":1759401268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19306590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":25,"alternative-id":["S0264410X19306590"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabies vaccine and immunoglobulin supply and logistics: Challenges and opportunities for rabies elimination in Kenya","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}